Pupillometry in healthy volunteers as a biomarker of tramadol efficacy

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 4, 2011, Pages 513-517

  Matouskova, O ^a   Slanar, O ^a   Chytil, L ^a   Perlik, F ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

CYP2D6; pharmacodynamics; pharmacogenetics; pupillometry; tramadol

Indexed keywords

CYTOCHROME P450 2D6; TRAMADOL;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MIOSIS; MYDRIASIS; NORMAL HUMAN; PROTEIN POLYMORPHISM; PUPIL; PUPIL REFLEX; PUPILLOMETRY; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALGESICS, OPIOID; BIOMARKERS, PHARMACOLOGICAL; CYTOCHROME P-450 CYP2D6; FEMALE; HUMANS; MALE; MIOSIS; MYDRIASIS; POLYMORPHISM, GENETIC; PUPIL; TRAMADOL; YOUNG ADULT;

EID: 79960083947     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01203.x     Document Type: Article

References (23)

1. Sokolski KN, Demet EM, (1996) Increased pupillary sensitivity to pilocarpine in depression. Progress in Neuro-psychopharmacology and Biological Psychiatry, 20, 253-262. (Pubitemid 26150439)
2. Fountoulakis K, Fotiou F, Iacovides A, et al. (1999) Changes in pupil reaction to light in melancholic patients. International Journal of Psychophysiology, 31, 121-128. (Pubitemid 29049404)
3. Idiaquez J, Alvarez G, Villagra R, et al. (1994) Cholinergic supersensitivity of the iris in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 57, 1544-1545.
4. Scinto LF, Daffner KR, Dressler D, et al. (1994) A potential noninvasive neurobiological test for Alzheimer's disease. Science, 266, 1051-1054. (Pubitemid 24373724)
5. Loupe DN, Newman NJ, Green RC, et al. (1996) Pupillary response to tropicamide in patients with Alzheimer disease. Ophthalmology, 103, 495-503. (Pubitemid 26085903)
6. Kurz A, Marquard R, Fremke S, et al. (1997) Pupil dilation response to tropicamide: a biological test for Alzheimer's disease. Pharmacopsychiatry, 30, 12-15. (Pubitemid 27083462)
7. Fotiou F, Fountoulakis KN, Goulas A, et al. (2000) Automated standardized pupillometry with optical method for purposes of clinical practice and research. Clinical Physiology, 20, 336-347.
8. Wensing G, Haase C, Brendel E, et al. (2007) Pupillography as a sensitive, noninvasive biomarker in healthy volunteers: first-in-man study of BAY 63-9044, a new 5-HT1A-receptor agonist with dopamine agonistic properties. European Journal of Clinical Pharmacology, 63, 1123-1128. (Pubitemid 350112761)
9. Lotsch J, Starke S, Grosch S, et al. (2002) The A118G single nucleotide polymorphism results in decreased pupil constrictory potency of moprhine-6-glucuronide in healthy volunteers: a population PK/PD-approach. Naunyn-Schmiedebergs Archives of Pharmacology, 365, 439.
10. Fliegert F, Kurth B, Gohler K, (2005) The effects of tramadol on static and dynamic pupillometry in healthy subjects-the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status. European Journal of Clinical Pharmacology, 61, 257-266. (Pubitemid 40884019)
11. Slanar O, Nobilis M, Kvetina J, et al. (2007) Miotic action of tramadol is determined by CYP2D6 genotype. Physiological Research, 56, 129-136.
12. Slanar O, Perlik F, (2004) CYP2D6 polymorphism and miotic effects of tramadol in healthy volunteers. Drug Metabolism Reviews, 36, 114.
13. Knaggs RD, Crighton IM, Cobby TF, et al. (2004) The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers. Anesthesia and Analgesia, 99, 108-112. (Pubitemid 38808174)
14. Krueger H, Muller-Limmroth W, (1978) Algo-pupillometric investigation of the analgesic effect of tramadol. Arzneimittel-Forschung, 28, 176-178. (Pubitemid 8260102)
15. Freye E, Latasch L, (2000) Effects of tramadol and tilidine/naloxone on oral-caecal transit and pupillary light reflex. Arzneimittel-Forschung, 50, 24-30. (Pubitemid 30062504)
16. Collart L, Luthy C, Favario-Constantin C, et al. (1993) Duality of the analgesic effect of tramadol in humans. Schweizerische Medizinische Wochenschrift, 123, 2241-2243. (Pubitemid 23353395)
17. Preston KL, Jasinski DR, Testa M, (1991) Abuse potential and pharmacological comparison of tramadol and morphine. Drug and Alcohol Dependence, 27, 7-17.
18. Weinhold LL, Bigelow GE, (1993) Opioid miosis-effects of lighting intensity and monocular and binocular exposure. Drug and Alcohol Dependence, 31, 177-181. (Pubitemid 23066508)
19. Buzkova H, Pechandova K, Slanar O, et al. (2008) Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population. Cellular Biochemistry and Function, 26, 76-81. (Pubitemid 351155271)
20. Poulsen L, Arendt-Nielsen L, Brosen K, et al. (1996) The hypoalgesic effect of tramadol in relation to CYP2D6. Clinical Pharmacology and Therapeutics, 60, 636-644. (Pubitemid 27025910)
21. Slanar O, Nobilis M, Kvetina J, et al. (2006) CYP2D6 polymorphism, tramadol pharmacokinetics and pupillary response. European Journal of Clinical Pharmacology, 62, 75-76. (Pubitemid 43106319)
22. Slanar O, Nobilis M, Kvetina J, et al. (2007) Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T. European Journal of Clinical Pharmacology, 63, 419-421. (Pubitemid 46399127)
23. Skarke C, Darimont J, Schmidt H, et al. (2003) Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clinical Pharmacology and Therapeutics, 73, 107-121. (Pubitemid 36158492)